pubmed-article:21304097 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0155626 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0026565 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0233820 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0205421 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
pubmed-article:21304097 | lifeskim:mentions | umls-concept:C1174136 | lld:lifeskim |
pubmed-article:21304097 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21304097 | pubmed:dateCreated | 2011-3-16 | lld:pubmed |
pubmed-article:21304097 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:abstractText | Prior studies demonstrate a direct relationship between treatment delays to primary percutaneous intervention and mortality in patients with ST-segment elevation myocardial infarction (STEMI). This analysis compared the relationship of symptom onset-to-balloon time and door-to-balloon time on mortality in patients with STEMI. | lld:pubmed |
pubmed-article:21304097 | pubmed:language | eng | lld:pubmed |
pubmed-article:21304097 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21304097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21304097 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21304097 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21304097 | pubmed:issn | 1941-7705 | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:ArmstrongPaul... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:GrangerChrist... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:WeaverW... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:HudsonMichael... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:StebbinsAmand... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:MahaffeyKenne... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:HolmesDavidD | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:AylwardPhilip... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:RuzylloWitold... | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:WidimskyPetrP | lld:pubmed |
pubmed-article:21304097 | pubmed:author | pubmed-author:O'NeilWilliam... | lld:pubmed |
pubmed-article:21304097 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21304097 | pubmed:volume | 4 | lld:pubmed |
pubmed-article:21304097 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21304097 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21304097 | pubmed:pagination | 183-92 | lld:pubmed |
pubmed-article:21304097 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:meshHeading | pubmed-meshheading:21304097... | lld:pubmed |
pubmed-article:21304097 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21304097 | pubmed:articleTitle | Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. | lld:pubmed |
pubmed-article:21304097 | pubmed:affiliation | Henry Ford Heart & Vascular Institute, Detroit, MI 48202, USA. mhudson1@hfhs.org | lld:pubmed |
pubmed-article:21304097 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21304097 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21304097 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |